Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3546 |
|
| Actual shortage: | 240 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3292 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2023-03-09 | 2023-04-14 | 186586 |
| APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216699 |
| APO-QUETIAPINE FUMARATE | 100MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-09-05 | 216702 |
| APO-QUETIAPINE FUMARATE | 200MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-09-05 | 216705 |
| APO-QUETIAPINE FUMARATE | 300MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216708 |
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-09 | 2020-11-03 | 66543 |
| APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-30 | 2020-11-03 | 74033 |
| APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-24 | 2020-11-03 | 76735 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-24 | 2020-11-03 | 76740 |
| APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156543 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156546 |
| APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156549 |
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2022-12-16 | 177672 |
| APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-08 | 2024-01-19 | 212969 |
| APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-11-14 | 216687 |
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-05-31 | 216690 |
| APO-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-11-14 | 216693 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-07-18 | 216696 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-02 | 453 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-06-05 | 463 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |